)
10X Genomics (TXG) investor relations material
10X Genomics TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business performance and financials
Achieved double-digit growth in Chromium and Spatial Consumables, despite a challenging CapEx environment and reliance on U.S. academic and government funding.
Ended the year with $100 million more cash, totaling $520 million, reflecting a strong balance sheet and focus on cash flow.
Guidance for 2026 projects 0%-4% underlying growth, assuming macro conditions similar to the second half of 2025.
CapEx for instrumentation expected to decline in the teens, offset by double-digit growth in Spatial Consumables, especially from the Xenium franchise.
Single-cell consumables, about half of the business, expected to be flat at the midpoint of guidance, with price-volume trade-offs from new product launches.
Product innovation and adoption
Launched Flex Apex in Q4, reducing pricing and unlocking new customer bases and applications.
Flex products, including Flex Apex, saw significant uptake, but not all customers or applications are expected to migrate immediately.
Price reductions are driving volume growth, with Q4 2025 showing over 30% volume increase and price declines in the 20% range.
Ongoing innovation with GEM-X and Flex products strengthens the product portfolio and customer feedback is positive.
Building a CLIA lab to offer services for both spatial and single-cell applications, aiming to make transactions more frictionless for biopharma customers.
Market trends and customer segments
U.S. academic and government funding was down more than the overall business, but growth in China and other regions provided bright spots.
Biopharma represents 20% of business today, with potential to grow to half; share of wallet in these accounts remains small.
Large-scale, AI-driven projects and public-private partnerships are emerging as new growth opportunities.
Customer enthusiasm for Xenium remains high, with opportunities to increase utilization within the existing install base.
Visium platform continues to have an enthusiastic customer base, though interest is shifting toward Xenium.
Next 10X Genomics earnings date
Next 10X Genomics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage